Technology·TechCrunch·12h agoUnited States
Denver Startup Grows Mini Guts to Test Drugs
Intero Biosystems ships living intestinal organoids to replace animal testing
Positive1 min readImportance
AI Summary
Denver-based Intero Biosystems is developing human intestinal organoids to test drugs, raising $2.3 million and generating over $400,000 in revenue as it competes for TechCrunch Disrupt's Startup Battlefield title.
Keywords
organoidsdrug developmentanimal testing alternativesbiotech startupFDA regulation
